Analysts think AMRN stock price could increase by 34%
May 07, 2025, 11:25 AM
14.42%
What does AMRN do
Amarin Plc is a pharmaceutical company focused on developing and commercializing cardiovascular therapeutics, primarily VASCEPA, which reduces triglyceride levels in patients with severe hypertriglyceridemia. VASCEPA is marketed through wholesalers and specialty pharmacies.
4 analysts think AMRN stock price will increase by 33.69%. The current median analyst target is $13.77 compared to a current stock price of $10.30. The lowest analysts target is $7.07 and the highest analyst target is $21.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
